VFA
TARS icon

Valeo Financial Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Valeo Financial Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
3,838
-4
-0.1% -$256 0.01% 697
2026
Q1 		$270K Sell
3,842
-73
-2% -$5.1K 0.01% 592
2025
Q4 		$321K Buy
3,915
+392
+11% +$29.3K 0.01% 597
2025
Q3 		$209K Buy
+3,523
New +$173K ﹤0.01% 740

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Valeo Financial Advisors's TARS Position: Q2 2026 in Review

Valeo Financial Advisors reduced its Tarsus Pharmaceuticals (TARS) stake by 0.1% in Q2 2026, selling an estimated $256 and leaving 3,838 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #697.

Valeo Financial Advisors first reported a position in TARS in Q3 2025 and has held it in 4 quarters since. The position peaked at $321K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Valeo Financial Advisors held 3,838 shares of Tarsus Pharmaceuticals worth $242K as of Q2 2026.
  • Valeo Financial Advisors sold 4 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $256.
  • Tarsus Pharmaceuticals made up 0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #697 holding.
  • Valeo Financial Advisors first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Valeo Financial Advisors's Tarsus Pharmaceuticals position peaked at $321K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.